Clinical Trials Browser

Phase 2 × OTHER × Patient Reported Outcome Measures × Clear all

NCT06019130 2024-05-16

NPC-Nivo

Phase 2 Recruiting

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT05932667 2023-12-21

DEMETER

Phase 2 Terminated

Breast Neoplasms

NCT02288078 2014-11-13

Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)

Phase 2 Unknown

Gastrointestinal

Fatigue, Rectal Neoplasms